ANKTIVA J Code: J9028

Drug & Product Overview

HCPCS Descriptor Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram

HCPCS Added Date January 1, 2025

Manufacturer Immunity Bio

Route of Administration Intravesical

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Solution

About ANKTIVA

Anktiva is a medication aligned to the HCPCS J Code: J9028 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravesical route and manufactured by Immunity Bio.

According to CMS Drug Use Information: This medication is used in combination with another medication (BCG) to treat certain types of bladder cancer. It works by causing the body's defense system (immune system) to become more active against bladder cancer cells. This medication may not cure your cancer. Delaying other treatment (such as surgery) could lead to a more serious condition (metastatic cancer). Discuss the risks and benefits of this medication with your doctor.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
81481-0803-01	Anktiva	Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc.	400	400 MCG / 0.4 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

ANKTIVA Pricing & Reimbursement

J9028 Private Payer Reimbursement

$97.66 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

ANKTIVA Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 31.55%

Avg. Days to File 9.2days

Avg. Days to Pay 25.8days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9028 claims analytics on FocalPoint →

ANKTIVA CPT Administration Codes

CPT Code	Description
51720	Bladder instillation of anticarcinogenic agent, including retention time

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

ANKTIVA Medically Unlikely Edits (MUE)

The most billing units of J9028 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mcg.

Practitioner Office & Hospital Outpatient

400 units / day

= 400 mcg per day

MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →

ANKTIVA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors

Drug Class

Interleukin-15 Receptor Agonist [EPC]Interleukin-15 Receptor Agonists [MoA]

Frequently Asked Questions

Is there an available ANKTIVA billing and coding guide?

Billing and coding information for ANKTIVA can be found through Immunity Bio Visit Here →

What are the available ANKTIVA patient assistance programs?

Our team has not identified a source of patient assistance information for ANKTIVA

Where can I find ANKTIVA prescribing information?

ANKTIVA prescribing information can be found at the link below. Visit Here →

Where can I find ANKTIVA side effect information?

ANKTIVA side effect information can be found through MedlinePlus at the link below.

Does billing ANKTIVA require JZ/JW wastage modifiers?

CMS does not include ANKTIVA (J9028) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9028. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.